{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihve3c7dnq3zu2f6jrxkeli7mzqpsd7b4ndz724jpewto3jblmlaq",
    "uri": "at://did:plc:wwyqal4cnqhuwyacdj7rqq3n/app.bsky.feed.post/3mklje2t46xe2"
  },
  "path": "/t/rms-semiparametric-ordinal-longitudinal-model/4819?page=6#post_116",
  "publishedAt": "2026-04-28T15:58:12.000Z",
  "site": "https://discourse.datamethods.org",
  "textContent": "Yes, averaging out is probably the better term. Do you know of any study that elicited utilities to the NIAID scale (through discussions with patients / doctors) ? We’re currently _not_ investigating this.\n\nFWIW: P(Benefit) in ACTT-2 was also higher when analysing the time to recovery compared to the Markov model, which I also did not expect. Working more extensive simulations and resampling studies currently, which to you disappointment, will be frequentist…",
  "title": "RMS Semiparametric Ordinal Longitudinal Model"
}